Goserelin, as an ovarian protector during (neo)adjuvant breast cancer chemotherapy, prevents long term altered bone turnover

Caroline Wilson, Fatma Gossiel, Robert Leonard, Richard A Anderson, Douglas J A Adamson, Geraldine Thomas, Robert E Coleman

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)43-49
JournalJournal of Bone Oncology
Issue number1
Early online date11 Feb 2016
Publication statusPublished - 1 Mar 2016

Cite this